RecruitingNCT07052604
Antibiotic Treatment for Pneumonia Caused by Stenotrophomonas Maltophilia in ICU Patients
Sponsor
Centre Hospitalier de Saint-Denis
Enrollment
300 participants
Start Date
Dec 15, 2023
Study Type
OBSERVATIONAL
Conditions
Summary
This study looks at how different antibiotic treatments affect patients in intensive care who have pneumonia caused by the bacteria Stenotrophomonas maltophilia. It compares using one antibiotic versus two antibiotics, and treatment lengths of 7 days versus 14 days, to see which approach helps patients survive better. The study also examines how resistant the bacteria are to antibiotics and how often the pneumonia comes back.
Eligibility
Min Age: 18 Years
Inclusion Criteria4
- Adult patients (age ≥ 18 years)
- Hospitalized in Medical Intensive Care Unit between January 1, 2018, and December 31, 2023
- Intubated and mechanically ventilated
- Diagnosed with ventilator-associated pneumonia caused by Stenotrophomonas maltophilia
Exclusion Criteria2
- Patients under 18 years old
- Patients who refuse the use of their data for research purposes
Interested in this trial?
Get notified about updates and connect with the research team.
Locations(1)
View Full Details on ClinicalTrials.gov
For the most up-to-date information, visit the official listing.
NCT07052604
Related Trials
Human Recombinant Interferon Gamma in the Treatment of Ventilator-acquired Pneumonia in ICU Patients
NCT058437869 locations
Clinical and Biological Signs of Dapagliflozin Overdose in ICU Patients With Metformin Poisoning
NCT071930691 location
Rapid Response Teams - How and Who?
NCT045077371 location
Comparison of Three Interventions for Antibiotic-Resistant Bacteria (ARB) Decolonization From the Gastrointestinal Tract
NCT070949841 location
Oscillometric Blood Pressure Measurement: Evaluation of the Effect of Wearing a Sleeve and the Type of Measurement Algorithm
NCT069998631 location